Cutaneous Adverse Effects of BRAF Inhibitors in Metastatic Malignant Melanoma: A Prospective Study in 20 Patients
March 2014
in “
Journal of the European Academy of Dermatology and Venereology
”
BRAF inhibitors vemurafenib dabrafenib alopecia cutaneous side effects verrucous papillomas keratoacanthomas squamous cell carcinomas hyperkeratotic eruptions facial erythema seborrhoeic dermatitis-like eczema cystic lesions hand–foot skin reactions hyperkeratosis phototoxic reactions skin side effects skin reactions hair loss
Studysummary In this study, multiple cutaneous adverse effects were observed in patients with metastatic malignant melanoma receiving BRAF inhibitors, but most were well managed with appropriate treatment.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on onlinelibrary.wiley.com →